首页 > 最新文献

Cardiology and cardiovascular medicine最新文献

英文 中文
Standardized Forearm Angiography Increases Procedural Success Rates of Coronary Angiography and PCI: A Retrospective Analysis of an all-Comers Patient Cohort in a Real-Life Scenario. 标准化前臂血管造影提高了冠状动脉造影和PCI的成功率:一项对现实生活中所有患者队列的回顾性分析。
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920250
Tobias Roeschl, Anas M Jano, Franziska Fochler, Mona M Grewe, Marlis Wacker, Kirstin Meier, Christian Schmidt, Lars Maier, Peter H Grewe

Background: There is a consensus, that Transradial-Access (TRA) for coronary procedures should be preferred over Transfemoral-Access (TFA). Previously, Forearm-Artery-Angiography (FA) was mainly performed when difficulties during the advancement of the guidewire/-catheter were encountered. We explored the implication of a Standardized Forearm-Angiography (SFA) on procedural success rates of TRA under real-world conditions.

Methods: In a single-center study, an all-comers-cohort of 1191 consecutive cases during 1/2020-12/2020 were assessed retrospectively. Primary TFA rates, crossover to TFA, reasons for Forearm-Artery-Access (FAA) failure, the prevalence of kinking at the level of the forearm and the occurrence of vascular complications were analyzed. Major forearm side branches including the common interosseus artery were assessed via SFA.

Results: In 1191 consecutive procedures, primary FAA access was attempted in 97.9% of cases. Crossover to TFA after a primary or secondary FAA attempt was necessary in 2.8%. Severe kinking was the most frequent cause of FAA failure and occurred in 3.0% of attempts. A second or third FAA attempt to avoid TFA was successful in 81%. Severe kinking at the level of the forearm was reported in 1.8% of procedures.

Conclusion: This is the first study to provide detailed success rates of a primary FAA strategy combined with a Standardized-Forearm-Angiography (SFA) in an all-comers-cohort. While severe kinking proved to be a rare but relevant challenge for FAA success, the prevalence of arterial spasm was marginal. Multiple attempts of FAA to avoid TFA might be safe possibly due to collateral blood supply by the common interosseus artery.

背景:在冠状动脉手术中,经桡骨通路(TRA)比经股骨通路(TFA)更可取。以前,前臂动脉血管造影(FA)主要是在导丝/导管在推进过程中遇到困难时进行的。我们探讨了标准前臂血管造影(SFA)对现实条件下TRA手术成功率的影响。方法:在一项单中心研究中,回顾性评估2020年1月至2020年12月期间1191例连续病例的所有患者队列。分析原发性TFA发生率、交叉TFA、前臂动脉通路(FAA)失败的原因、前臂水平扭结的发生率和血管并发症的发生。通过SFA评估包括骨间总动脉在内的前臂主要侧分支。结果:在1191例连续手术中,97.9%的病例尝试了一级FAA通道。在首次或二次FAA尝试后,有2.8%的患者需要转行TFA。严重扭结是FAA失败的最常见原因,发生在3.0%的尝试中。第二次或第三次FAA尝试避免TFA的成功率为81%。在1.8%的手术中报告了前臂水平的严重扭结。结论:这是第一个在所有患者队列中提供主要FAA策略结合标准化前臂血管造影(SFA)的详细成功率的研究。虽然严重扭结被证明是FAA成功的罕见但相关的挑战,但动脉痉挛的患病率很低。由于骨间总动脉的侧支供血,多次尝试FAA避免TFA可能是安全的。
{"title":"Standardized Forearm Angiography Increases Procedural Success Rates of Coronary Angiography and PCI: A Retrospective Analysis of an all-Comers Patient Cohort in a Real-Life Scenario.","authors":"Tobias Roeschl,&nbsp;Anas M Jano,&nbsp;Franziska Fochler,&nbsp;Mona M Grewe,&nbsp;Marlis Wacker,&nbsp;Kirstin Meier,&nbsp;Christian Schmidt,&nbsp;Lars Maier,&nbsp;Peter H Grewe","doi":"10.26502/fccm.92920250","DOIUrl":"https://doi.org/10.26502/fccm.92920250","url":null,"abstract":"<p><strong>Background: </strong>There is a consensus, that Transradial-Access (TRA) for coronary procedures should be preferred over Transfemoral-Access (TFA). Previously, Forearm-Artery-Angiography (FA) was mainly performed when difficulties during the advancement of the guidewire/-catheter were encountered. We explored the implication of a Standardized Forearm-Angiography (SFA) on procedural success rates of TRA under real-world conditions.</p><p><strong>Methods: </strong>In a single-center study, an all-comers-cohort of 1191 consecutive cases during 1/2020-12/2020 were assessed retrospectively. Primary TFA rates, crossover to TFA, reasons for Forearm-Artery-Access (FAA) failure, the prevalence of kinking at the level of the forearm and the occurrence of vascular complications were analyzed. Major forearm side branches including the common interosseus artery were assessed via SFA.</p><p><strong>Results: </strong>In 1191 consecutive procedures, primary FAA access was attempted in 97.9% of cases. Crossover to TFA after a primary or secondary FAA attempt was necessary in 2.8%. Severe kinking was the most frequent cause of FAA failure and occurred in 3.0% of attempts. A second or third FAA attempt to avoid TFA was successful in 81%. Severe kinking at the level of the forearm was reported in 1.8% of procedures.</p><p><strong>Conclusion: </strong>This is the first study to provide detailed success rates of a primary FAA strategy combined with a Standardized-Forearm-Angiography (SFA) in an all-comers-cohort. While severe kinking proved to be a rare but relevant challenge for FAA success, the prevalence of arterial spasm was marginal. Multiple attempts of FAA to avoid TFA might be safe possibly due to collateral blood supply by the common interosseus artery.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"6 2","pages":"124-136"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10545438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD4+CD25+Treg Cells Prolong the Survival Time of Heart Allograft Via Induction Lymphocyte Apoptosis and Modulation the Ratio of T Cell Subsets CD4+CD25+Treg细胞通过诱导淋巴细胞凋亡和调节T细胞亚群比例延长同种异体心脏移植存活时间
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920245
Jinguo Zhu, L. Xiong
Background: CD4CD25regulatory T cells (CD4CD25 Treg cells) play major roles in immune regulation. Previous studies showed CD4CD25 Treg cells can maintain peripheral immune tolerance and increase the survival time of transplanted organs. However, the biological characteristics and the functional roles of these CD4CD25 Treg cells in transplantation tolerance remain unknown. The current study was conducted to observe the effect of CD4CD25 Treg cells on heart allograft in rats and to investigate the underlying mechanism of the CD4CD25 Treg cells. Methods: 5 x 10 spleen cells of SD rats were inoculated into the thymus gland of Wistar rats. The level of CD4CD25 Treg cells was examined by the flow cytometry method, and the biological activity of CD4CD25 Treg cells was detected by the H-TdR method. Hearts were transplanted from SD rats (donors) to Wistar rats (recipients) and the animals were assigned into four groups: HT, HT+Ii,HT+Treg, HT+Treg+Ii. At various time points after the transplantation, the transplanted hearts were collected and histologically examined. The rate of lymphocyte Cardiol Cardiovasc Med 2022; 6 (2): 71-82 DOI: 10.26502/fccm.92920245 Cardiology and Cardiovascular Medicine Vol. 6 No. 2 – April 2022. [ISSN 2572-9292] 72 apoptosis and T cell subsets in the peripheral blood of Wistar rats were analyzed with flow cytometry. Results: The CD4+CD25+ Treg cells in Wistar rats were sharply increased, and these CD4CD25 Treg cells significantly extended the survival time: The mean survival time of the transplanted hearts was 8.1 ± 1.2 days, 35.7 ± 4.7 days,53.7 ± 6.2 days, 75.7 ± 11.3 days in the group of HT, HT+Ii, HT+Treg, or HT+Ii+Treg, respectively (n = 12-14/group). Among them, the survival time between HT and HT+Treg or between HT and HT+Treg+Ii was significantly different (p<0.001). Also, we found that CD4CD25 Treg cells improved the pathological changes of the transplanted hearts, increased the rate of lymphocyte apoptosis, upregulated CD3CD8T cells, and suppressed CD3CD4 T cells. Conclusions: CD4CD25 Treg cells appear to be able to induce tolerance in heart transplantation. This is largely due to the CD4CD25 Treg cellsdependent alteration of the ratio of T cell subsets and the induction of lymphocyte apoptosis.
背景:CD4CD25调节性T细胞(CD4CD25 Treg细胞)在免疫调节中发挥重要作用。既往研究表明,CD4CD25 Treg细胞可维持外周免疫耐受,延长移植器官存活时间。然而,这些CD4CD25 Treg细胞在移植耐受中的生物学特性和功能作用尚不清楚。本研究旨在观察CD4CD25 Treg细胞对大鼠同种异体心脏移植的作用,并探讨其作用机制。方法:取SD大鼠5 × 10个脾细胞接种Wistar大鼠胸腺。流式细胞术检测CD4CD25 Treg细胞水平,H-TdR法检测CD4CD25 Treg细胞的生物活性。将SD大鼠(供体)的心脏移植给Wistar大鼠(受体),分为HT、HT+Ii、HT+Treg、HT+Treg+Ii四组。在移植后的不同时间点收集移植心脏并进行组织学检查。心血管医学2022年淋巴细胞率;6 (2): 71-82 DOI: 10.26502/fccm.92920245心脏病学和心血管医学第6卷第2期- 2022年4月。[ISSN 2572-9292]用流式细胞术分析Wistar大鼠外周血中72个细胞凋亡和T细胞亚群的变化。结果:Wistar大鼠体内CD4+CD25+ Treg细胞显著增加,CD4CD25 +Treg细胞显著延长存活时间:HT、HT+Ii、HT+Treg、HT+Ii+Treg组移植心脏平均存活时间分别为8.1±1.2天、35.7±4.7天、53.7±6.2天、75.7±11.3天(n = 12-14/组)。其中,HT与HT+Treg、HT与HT+Treg+Ii的存活时间差异有统计学意义(p<0.001)。此外,我们发现CD4CD25 Treg细胞改善了移植心脏的病理改变,增加了淋巴细胞凋亡率,上调了CD3CD8T细胞,抑制了CD3CD4 T细胞。结论:CD4CD25 Treg细胞似乎能够诱导心脏移植耐受。这主要是由于CD4CD25 Treg细胞依赖性T细胞亚群比例的改变和淋巴细胞凋亡的诱导。
{"title":"CD4+CD25+Treg Cells Prolong the Survival Time of Heart Allograft Via Induction Lymphocyte Apoptosis and Modulation the Ratio of T Cell Subsets","authors":"Jinguo Zhu, L. Xiong","doi":"10.26502/fccm.92920245","DOIUrl":"https://doi.org/10.26502/fccm.92920245","url":null,"abstract":"Background: CD4CD25regulatory T cells (CD4CD25 Treg cells) play major roles in immune regulation. Previous studies showed CD4CD25 Treg cells can maintain peripheral immune tolerance and increase the survival time of transplanted organs. However, the biological characteristics and the functional roles of these CD4CD25 Treg cells in transplantation tolerance remain unknown. The current study was conducted to observe the effect of CD4CD25 Treg cells on heart allograft in rats and to investigate the underlying mechanism of the CD4CD25 Treg cells. Methods: 5 x 10 spleen cells of SD rats were inoculated into the thymus gland of Wistar rats. The level of CD4CD25 Treg cells was examined by the flow cytometry method, and the biological activity of CD4CD25 Treg cells was detected by the H-TdR method. Hearts were transplanted from SD rats (donors) to Wistar rats (recipients) and the animals were assigned into four groups: HT, HT+Ii,HT+Treg, HT+Treg+Ii. At various time points after the transplantation, the transplanted hearts were collected and histologically examined. The rate of lymphocyte Cardiol Cardiovasc Med 2022; 6 (2): 71-82 DOI: 10.26502/fccm.92920245 Cardiology and Cardiovascular Medicine Vol. 6 No. 2 – April 2022. [ISSN 2572-9292] 72 apoptosis and T cell subsets in the peripheral blood of Wistar rats were analyzed with flow cytometry. Results: The CD4+CD25+ Treg cells in Wistar rats were sharply increased, and these CD4CD25 Treg cells significantly extended the survival time: The mean survival time of the transplanted hearts was 8.1 ± 1.2 days, 35.7 ± 4.7 days,53.7 ± 6.2 days, 75.7 ± 11.3 days in the group of HT, HT+Ii, HT+Treg, or HT+Ii+Treg, respectively (n = 12-14/group). Among them, the survival time between HT and HT+Treg or between HT and HT+Treg+Ii was significantly different (p<0.001). Also, we found that CD4CD25 Treg cells improved the pathological changes of the transplanted hearts, increased the rate of lymphocyte apoptosis, upregulated CD3CD8T cells, and suppressed CD3CD4 T cells. Conclusions: CD4CD25 Treg cells appear to be able to induce tolerance in heart transplantation. This is largely due to the CD4CD25 Treg cellsdependent alteration of the ratio of T cell subsets and the induction of lymphocyte apoptosis.","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventricular Hyper-Excitability Revealing Cardiac and Mediastino-Pulmonary Sarcoidosis 心室高兴奋性揭示心脏和纵隔肺结节病
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920292
H. Mokhlis
Sarcoidosis, also known as Besnier-Boeck-Schaumann disease, first described in 1877 [1], is a systemic granulomatous disease that affects multiple organs (nervous system, heart, liver and kidneys.. ....), but mainly affects the lungs and lymph glands. Sarcoidosis has no known cause, and it can affect a wide range of people and present a real diagnostic challenge. Cardiac sarcoidosis can manifest as complete heart block, ventricular arrhythmias, congestive heart failure, pulmonary hypertension, and ventricular aneurysms.
结节病,又称Besnier-Boeck-Schaumann病,于1877年首次被描述,是一种累及多器官(神经系统、心脏、肝脏和肾脏.. ....)的系统性肉芽肿性疾病,但主要累及肺部和淋巴腺。结节病没有已知的原因,它可以影响广泛的人,并提出了一个真正的诊断挑战。心脏结节病可表现为完全性心脏传导阻滞、室性心律失常、充血性心力衰竭、肺动脉高压和心室动脉瘤。
{"title":"Ventricular Hyper-Excitability Revealing Cardiac and Mediastino-Pulmonary Sarcoidosis","authors":"H. Mokhlis","doi":"10.26502/fccm.92920292","DOIUrl":"https://doi.org/10.26502/fccm.92920292","url":null,"abstract":"Sarcoidosis, also known as Besnier-Boeck-Schaumann disease, first described in 1877 [1], is a systemic granulomatous disease that affects multiple organs (nervous system, heart, liver and kidneys.. ....), but mainly affects the lungs and lymph glands. Sarcoidosis has no known cause, and it can affect a wide range of people and present a real diagnostic challenge. Cardiac sarcoidosis can manifest as complete heart block, ventricular arrhythmias, congestive heart failure, pulmonary hypertension, and ventricular aneurysms.","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of D-Dimer Levels in Various Subgroups of Atrial Fibrillation: Role in Risk Stratification 评价房颤不同亚组的d -二聚体水平:在危险分层中的作用
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920300
Avinash Mani, V. Ojha, Pradip Kumar Sinha, Jayanta Saha
Results: 70 patients with AF were studied over a one-year period. Mean age of study population was 53 years. Valvular AF was the most common etiology(30%) noted followed by non-ischemic cardiomyopathy (NICM) (14.2%). About half of study population had history of heart failure whereas thromboembolism(TE) was noted in 15.7%. 72.8% patients had elevated D-dimer levels in the cohort. D-dimer levels were significantly higher in valvular AF(1.2 μg/ml) and NICM patients(1.4 μg/ml) (p=0.005). Higher D-dimer levels were noted in those with heart failure (HF) events (p=0.016). D-dimer levels were shown to accurately detect prior HF/ TE events with levels of 1.1 μg/ml and higher having a sensitivity and specificity of 59.1% and 81%, respectively (AUC 0.727).
结果:对70例房颤患者进行了为期一年的研究。研究人群的平均年龄为53岁。瓣膜性房颤是最常见的病因(30%),其次是非缺血性心肌病(NICM)(14.2%)。大约一半的研究人群有心力衰竭史,而15.7%的人有血栓栓塞(TE)。72.8%的患者d -二聚体水平升高。d -二聚体水平在瓣膜性房颤(1.2 μg/ml)和NICM患者(1.4 μg/ml)中显著升高(p=0.005)。心力衰竭(HF)患者的d -二聚体水平较高(p=0.016)。d -二聚体水平可准确检测出1.1 μg/ml及以上的HF/ TE事件,灵敏度和特异性分别为59.1%和81% (AUC为0.727)。
{"title":"Evaluation of D-Dimer Levels in Various Subgroups of Atrial Fibrillation: Role in Risk Stratification","authors":"Avinash Mani, V. Ojha, Pradip Kumar Sinha, Jayanta Saha","doi":"10.26502/fccm.92920300","DOIUrl":"https://doi.org/10.26502/fccm.92920300","url":null,"abstract":"Results: 70 patients with AF were studied over a one-year period. Mean age of study population was 53 years. Valvular AF was the most common etiology(30%) noted followed by non-ischemic cardiomyopathy (NICM) (14.2%). About half of study population had history of heart failure whereas thromboembolism(TE) was noted in 15.7%. 72.8% patients had elevated D-dimer levels in the cohort. D-dimer levels were significantly higher in valvular AF(1.2 μg/ml) and NICM patients(1.4 μg/ml) (p=0.005). Higher D-dimer levels were noted in those with heart failure (HF) events (p=0.016). D-dimer levels were shown to accurately detect prior HF/ TE events with levels of 1.1 μg/ml and higher having a sensitivity and specificity of 59.1% and 81%, respectively (AUC 0.727).","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Nucleus RNA-sequencing Reveals Altered Intercellular Communication and Dendritic Cell Activation in Nonobstructive Hypertrophic Cardiomyopathy. 单核rna测序揭示非阻塞性肥厚性心肌病细胞间通讯和树突状细胞活化的改变。
Pub Date : 2022-01-01 Epub Date: 2022-08-19 DOI: 10.26502/fccm.92920277
Christina J Codden, Amy Larson, Junya Awata, Gayani Perera, Michael T Chin

End stage, nonobstructive hypertrophic cardiomyopathy (HCM) is an intractable condition with no disease-specific therapies. To gain insights into the pathogenesis of nonobstructive HCM, we performed single nucleus RNA-sequencing (snRNA-seq) on human HCM hearts explanted at the time of cardiac transplantation and organ donor hearts serving as controls. Differential gene expression analysis revealed 64 differentially expressed genes linked to specific cell types and molecular functions. Analysis of ligand-receptor pair gene expression to delineate potential intercellular communication revealed significant reductions in expressed ligand-receptor pairs likely affecting the extracellular matrix, growth factor binding, peptidase regulator activity, platelet-derived growth factor binding and protease binding in the HCM tissue. Changes in Integrin-β1 receptor expression were responsible for many observed changes related to extracellular matrix interactions, by increasing in dendritic, smooth muscle and pericyte cells while decreasing in endothelial and fibroblast cells, suggesting potential mechanisms for fibrosis and microvascular disease in HCM and a potential role for dendritic cells. In contrast, there was an increase in ligand-receptor pair expression associated with adenylate cyclase binding, calcium channel molecular functions, channel inhibitor activity, ion channel inhibitor activity, phosphatase activator activity, protein kinase activator activity and titin binding, suggesting important shifts in various signaling cascades in nonobstructive, end stage HCM.

终末期,非阻塞性肥厚性心肌病(HCM)是一种难治性疾病,没有疾病特异性治疗方法。为了深入了解非阻塞性HCM的发病机制,我们对心脏移植时移植的人类HCM心脏和作为对照的器官供体心脏进行了单核rna测序(snRNA-seq)。差异基因表达分析揭示了64个与特定细胞类型和分子功能相关的差异表达基因。通过对配体-受体对基因表达的分析来描述潜在的细胞间通讯,结果显示,在HCM组织中,表达的配体-受体对的显著减少可能影响细胞外基质、生长因子结合、肽酶调节活性、血小板来源的生长因子结合和蛋白酶结合。整合素-β1受体表达的变化是许多观察到的与细胞外基质相互作用相关的变化的原因,在树突状、平滑肌和周细胞中表达增加,而在内皮细胞和成纤维细胞中表达减少,这表明HCM中纤维化和微血管疾病的潜在机制以及树突状细胞的潜在作用。相反,与腺苷酸环化酶结合、钙通道分子功能、通道抑制剂活性、离子通道抑制剂活性、磷酸酶激活剂活性、蛋白激酶激活剂活性和titin结合相关的配体受体对表达增加,表明非阻塞性终末期HCM中各种信号级联发生了重要变化。
{"title":"Single Nucleus RNA-sequencing Reveals Altered Intercellular Communication and Dendritic Cell Activation in Nonobstructive Hypertrophic Cardiomyopathy.","authors":"Christina J Codden,&nbsp;Amy Larson,&nbsp;Junya Awata,&nbsp;Gayani Perera,&nbsp;Michael T Chin","doi":"10.26502/fccm.92920277","DOIUrl":"https://doi.org/10.26502/fccm.92920277","url":null,"abstract":"<p><p>End stage, nonobstructive hypertrophic cardiomyopathy (HCM) is an intractable condition with no disease-specific therapies. To gain insights into the pathogenesis of nonobstructive HCM, we performed single nucleus RNA-sequencing (snRNA-seq) on human HCM hearts explanted at the time of cardiac transplantation and organ donor hearts serving as controls. Differential gene expression analysis revealed 64 differentially expressed genes linked to specific cell types and molecular functions. Analysis of ligand-receptor pair gene expression to delineate potential intercellular communication revealed significant reductions in expressed ligand-receptor pairs likely affecting the extracellular matrix, growth factor binding, peptidase regulator activity, platelet-derived growth factor binding and protease binding in the HCM tissue. Changes in Integrin-β1 receptor expression were responsible for many observed changes related to extracellular matrix interactions, by increasing in dendritic, smooth muscle and pericyte cells while decreasing in endothelial and fibroblast cells, suggesting potential mechanisms for fibrosis and microvascular disease in HCM and a potential role for dendritic cells. In contrast, there was an increase in ligand-receptor pair expression associated with adenylate cyclase binding, calcium channel molecular functions, channel inhibitor activity, ion channel inhibitor activity, phosphatase activator activity, protein kinase activator activity and titin binding, suggesting important shifts in various signaling cascades in nonobstructive, end stage HCM.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":" ","pages":"398-415"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33509131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Association of Increased Risk of Atherosclerotic Cardiovascular (ASCVD) Event in Chronic Liver Disease Patients with and without Cirrhosis 合并和不合并肝硬化的慢性肝病患者动脉粥样硬化性心血管(ASCVD)事件风险增加的相关性
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920242
L. Hashemi, Cachet Magdolna Wenziger, Tran Do, Arpan A. Patel, J. Pisegna, T. Ganz, M. Budoff, J. Gornbein, David A. Elashoff, E. Streja
Background: An area of debate in modern medicine is whether there is an association between cirrhosis and Atherosclerotic Cardiovascular Disease (ASCVD). To address this we conducted a retrospective cohort study composed of the 486,887 US Veterans with liver disease over the period of January 2000 to December 2019 to ascertain whether there is an association between cirrhosis and ASCVD. We further divided the cohort based on a diagnosis of cirrhosis. Cox-Regression, negative binomial and competing risk models were used to investigate the time interval between the first and recurrent ASCVD hospitalization with mortality as a competing event risk. The mean± SD age of the cohort was 58  11 years, 4.6% were female, 63% White, 21% Black. 58% of the cohort had liver disease without a diagnosis of cirrhosis. The incidence of ASCVD hospitalization was much higher in liver patients with diagnosis of cirrhosis (11% vs 6%, p value<0.001). In a non-adjusted model with cirrhosis as the exposure the rate of first ASCVD hospitalization was 1.5 times higher than liver disease in patients without cirrhosis (HR: 1.49 (95%CI: 1.471.50), p <0.001). In a fully adjusted model, the risk was attenuated but remained statistically significant (HR: 1.03 (95% CI:1.02-1.04, p <0.001)). The mean number of ASCVD hospitalizations in a count model was 30% lower in the cirrhosis group (mean count ratio 0.70 (95% CI: 0.68-.072)), due to higher competing risk of all-cause mortality with ASCVD events (0.77 (0.73-0.81)). Conclusion: We demonstrate in this retrospective cohort study that as liver disease progresses to cirrhosis, the risk of ASCVD events increases. We hypothesize that the pro-inflammatory states of liver disease could be a viable explanation for the increased risk of ASCVD events in cirrhosis patients. Further translational studies are needed to confirm this hypothesis.
背景:肝硬化与动脉粥样硬化性心血管疾病(ASCVD)之间是否存在关联是现代医学中争论的一个领域。为了解决这个问题,我们对2000年1月至2019年12月期间患有肝病的486887名美国退伍军人进行了一项回顾性队列研究,以确定肝硬化和ASCVD之间是否存在关联。我们根据肝硬化的诊断进一步划分队列。采用cox -回归、负二项和竞争风险模型来研究首次和复发ASCVD住院之间的时间间隔,并将死亡率作为竞争事件风险。队列的平均±SD年龄为5811岁,4.6%为女性,63%为白人,21%为黑人。58%的队列患有肝脏疾病,但未诊断为肝硬化。诊断为肝硬化的肝脏患者的ASCVD住院率要高得多(11%比6%,p值<0.001)。在以肝硬化为暴露的非校正模型中,ASCVD首次住院率是无肝硬化患者的1.5倍(HR: 1.49 (95%CI: 1.471.50), p <0.001)。在完全调整的模型中,风险降低,但仍具有统计学意义(HR: 1.03 (95% CI:1.02-1.04, p <0.001))。在计数模型中,肝硬化组ASCVD住院的平均次数减少了30%(平均计数比0.70 (95% CI: 0.68- 0.072)),这是由于ASCVD事件与全因死亡的竞争风险较高(0.77(0.73-0.81))。结论:我们在这项回顾性队列研究中证明,随着肝病进展为肝硬化,ASCVD事件的风险增加。我们假设肝脏疾病的促炎状态可能是肝硬化患者ASCVD事件风险增加的一个可行解释。需要进一步的翻译研究来证实这一假设。
{"title":"Association of Increased Risk of Atherosclerotic Cardiovascular (ASCVD) Event in Chronic Liver Disease Patients with and without Cirrhosis","authors":"L. Hashemi, Cachet Magdolna Wenziger, Tran Do, Arpan A. Patel, J. Pisegna, T. Ganz, M. Budoff, J. Gornbein, David A. Elashoff, E. Streja","doi":"10.26502/fccm.92920242","DOIUrl":"https://doi.org/10.26502/fccm.92920242","url":null,"abstract":"Background: An area of debate in modern medicine is whether there is an association between cirrhosis and Atherosclerotic Cardiovascular Disease (ASCVD). To address this we conducted a retrospective cohort study composed of the 486,887 US Veterans with liver disease over the period of January 2000 to December 2019 to ascertain whether there is an association between cirrhosis and ASCVD. We further divided the cohort based on a diagnosis of cirrhosis. Cox-Regression, negative binomial and competing risk models were used to investigate the time interval between the first and recurrent ASCVD hospitalization with mortality as a competing event risk. The mean± SD age of the cohort was 58  11 years, 4.6% were female, 63% White, 21% Black. 58% of the cohort had liver disease without a diagnosis of cirrhosis. The incidence of ASCVD hospitalization was much higher in liver patients with diagnosis of cirrhosis (11% vs 6%, p value<0.001). In a non-adjusted model with cirrhosis as the exposure the rate of first ASCVD hospitalization was 1.5 times higher than liver disease in patients without cirrhosis (HR: 1.49 (95%CI: 1.471.50), p <0.001). In a fully adjusted model, the risk was attenuated but remained statistically significant (HR: 1.03 (95% CI:1.02-1.04, p <0.001)). The mean number of ASCVD hospitalizations in a count model was 30% lower in the cirrhosis group (mean count ratio 0.70 (95% CI: 0.68-.072)), due to higher competing risk of all-cause mortality with ASCVD events (0.77 (0.73-0.81)). Conclusion: We demonstrate in this retrospective cohort study that as liver disease progresses to cirrhosis, the risk of ASCVD events increases. We hypothesize that the pro-inflammatory states of liver disease could be a viable explanation for the increased risk of ASCVD events in cirrhosis patients. Further translational studies are needed to confirm this hypothesis.","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Ischemic Stroke Patients for Alteplase or Medical Care Alone or Intervention with/without Alteplase in Palestine (AIS-AMI Palestine) 巴勒斯坦急性缺血性卒中患者阿替普酶或单独医疗护理或加/不加阿替普酶干预(AIS-AMI巴勒斯坦)
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920294
M. Habib, Majed Alshounat, Mohammed Salama
{"title":"Acute Ischemic Stroke Patients for Alteplase or Medical Care Alone or Intervention with/without Alteplase in Palestine (AIS-AMI Palestine)","authors":"M. Habib, Majed Alshounat, Mohammed Salama","doi":"10.26502/fccm.92920294","DOIUrl":"https://doi.org/10.26502/fccm.92920294","url":null,"abstract":"","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyphenols could be Effective in Exerting a Disinfectant-Like Action on Bioprosthetic Heart Valves, Counteracting Bacterial Adhesiveness. 多酚类物质可以有效地对生物假体心脏瓣膜发挥类似消毒剂的作用,抵消细菌的粘附性。
Pub Date : 2022-01-01 Epub Date: 2022-09-30 DOI: 10.26502/fccm.92920287
Filippo Naso, Antonio Maria Calafiore, Mario Gaudino, Peter Zilla, Axel Haverich, Andrea Colli, Robert John Melder, Alessandro Gandaglia

Background: The incidence of infective endocarditis in patients with bioprosthetic heart valves is over 100 times that of the general population with S. aureus recognized as the causative organism in approximately 1/3 of cases. In this study, (1) the microbicidal and virucidal effect of a polyphenolic solution was carefully evaluated. The same solution was then adopted for the treatment of a commercial bioprosthetic heart valve model for (2) the assessment of inhibition of S. aureus adhesiveness.

Methods: (1) the viability of 9 microorganisms strains (colony-forming units) and the infectivity degree of 3 viral strains (cellular infection capacity) were evaluated after suspension in the polyphenolic solution. (2) Leaflets from a treated and untreated commercial surgical valve model were incubated with a known concentration of S. aureus. After incubation, the leaflets were homogenized and placed in specific culture media to quantify the bacterial load.

Results: (1) The polyphenolic solution proved to be effective in eliminating microorganisms strains guaranteeing the killing of at least 99.9%. The effectiveness is particularly relevant against M. chelonae (99.999%). (2) The polyphenol-based treatment resulted in the inhibition of the S. aureus adhesiveness by 96% concerning untreated samples.

Conclusions: The data suggest an interesting protective effect against infections and bacterial adhesiveness by a polyphenolic-based solution. Further studies will plan to extend the panel of microorganisms for the evaluation of the anti-adhesive effect; however, the use of optimized polyphenolic blends could lead to the development of new treatments capable to make transcatheter-valve substitutes more resistant to infection.

背景:生物人工心脏瓣膜患者感染性心内膜炎的发生率是普通人群的100倍以上,其中约1/3的病例被认为是金黄色葡萄球菌的致病菌。在这项研究中,(1)仔细评估了多酚溶液的杀微生物和杀病毒效果。然后采用相同的溶液处理商业生物假体心脏瓣膜模型,用于(2)评估金黄色葡萄球菌粘附性的抑制作用。方法:(1)在多酚溶液中悬浮后,评价9株微生物(菌落形成单位)的活力和3株病毒的感染性程度(细胞感染能力)。(2)将处理过和未处理过的商业手术瓣膜模型小叶与已知浓度的金黄色葡萄球菌孵育。孵育后,将小叶匀浆并置于特定培养基中以量化细菌负荷。结果:(1)多酚溶液对微生物有较好的杀灭效果,杀菌率达到99.9%以上。对龟分枝杆菌的有效性尤其显著(99.999%)。(2)多酚基处理对金黄色葡萄球菌黏附性的抑制率为96%。结论:这些数据表明,多酚基溶液对感染和细菌粘附具有有趣的保护作用。进一步的研究将计划扩大微生物小组,以评估抗粘著效果;然而,使用优化的多酚混合物可能会导致新的治疗方法的发展,使经导管瓣膜替代品更具抗感染能力。
{"title":"Polyphenols could be Effective in Exerting a Disinfectant-Like Action on Bioprosthetic Heart Valves, Counteracting Bacterial Adhesiveness.","authors":"Filippo Naso,&nbsp;Antonio Maria Calafiore,&nbsp;Mario Gaudino,&nbsp;Peter Zilla,&nbsp;Axel Haverich,&nbsp;Andrea Colli,&nbsp;Robert John Melder,&nbsp;Alessandro Gandaglia","doi":"10.26502/fccm.92920287","DOIUrl":"https://doi.org/10.26502/fccm.92920287","url":null,"abstract":"<p><strong>Background: </strong>The incidence of infective endocarditis in patients with bioprosthetic heart valves is over 100 times that of the general population with <i>S. aureus</i> recognized as the causative organism in approximately 1/3 of cases. In this study, (1) the microbicidal and virucidal effect of a polyphenolic solution was carefully evaluated. The same solution was then adopted for the treatment of a commercial bioprosthetic heart valve model for (2) the assessment of inhibition of <i>S. aureus</i> adhesiveness.</p><p><strong>Methods: </strong>(1) the viability of 9 microorganisms strains (colony-forming units) and the infectivity degree of 3 viral strains (cellular infection capacity) were evaluated after suspension in the polyphenolic solution. (2) Leaflets from a treated and untreated commercial surgical valve model were incubated with a known concentration of <i>S. aureus</i>. After incubation, the leaflets were homogenized and placed in specific culture media to quantify the bacterial load.</p><p><strong>Results: </strong>(1) The polyphenolic solution proved to be effective in eliminating microorganisms strains guaranteeing the killing of at least 99.9%. The effectiveness is particularly relevant against <i>M. chelonae</i> (99.999%). (2) The polyphenol-based treatment resulted in the inhibition of the S. aureus adhesiveness by 96% concerning untreated samples.</p><p><strong>Conclusions: </strong>The data suggest an interesting protective effect against infections and bacterial adhesiveness by a polyphenolic-based solution. Further studies will plan to extend the panel of microorganisms for the evaluation of the anti-adhesive effect; however, the use of optimized polyphenolic blends could lead to the development of new treatments capable to make transcatheter-valve substitutes more resistant to infection.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":" ","pages":"487-492"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40652304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Impact of Coronavirus-19 Pandemic and Lockdown on Admissions for Ischemic Heart Disease. 冠状病毒19大流行和封锁对缺血性心脏病入院的影响
Pub Date : 2022-01-01 DOI: 10.26502/fccm.92920270
Juan Enrique Puche García, Marta Iturregui Guevara, Etelvino Silva García, Raquel Campuzano Ruiz, Rafael Vázquez García

Background: In early 2020, the SARS-CoV-2 pandemic caused an unprecedented overload for the health service. A decrease in admissions for Acute Coronary Syndrome (ACS) was reported during lockdown, although many aspects remain to be clarified. The main objective of this study was to evaluate the impact of the pandemic and of lockdown itself in this area.

Methods: We performed a retrospective observational study based on data from patients who visited the emergency department of a tertiary hospital with chest pain during 2018-2020, as well as those who were admitted for ACS. Personal details, date of admission, additional test results (laboratory and echocardiography), and therapy were recorded. Patients were divided into 3 groups: preCOVID (n=1,301), lockdown (n=45), and postlockdown (n=343).

Results: Fewer visits to the emergency department for chest pain and admissions for ACS were recorded during lockdown (48.6% and 51.1% respectively, p<0.05). Patients who were admitted during lockdown were characterized by poorer control of cardiovascular risk factors, visited later (more evolving infarctions: 2.7% vs. 14.3%, p<0.05), experienced more echocardiographic complications during admission, and had more than 3-fold mortality rates (both in-hospital and postdischarge).

Conclusion: The COVID-19 pandemic and lockdown itself had a negative effect on ischemic heart disease beyond SARS-CoV-2 infection.

背景:2020年初,SARS-CoV-2大流行给卫生服务造成了前所未有的超负荷。据报道,在封锁期间,急性冠状动脉综合征(ACS)入院人数有所减少,但许多方面仍有待澄清。这项研究的主要目的是评估大流行和封锁本身对该地区的影响。方法:我们基于2018-2020年期间在某三级医院急诊科就诊的胸痛患者以及因ACS入院的患者的数据进行了回顾性观察研究。记录个人信息、入院日期、其他检查结果(实验室和超声心动图)和治疗情况。患者分为3组:covid前(n=1,301)、封锁(n=45)和封锁后(n=343)。结果:在封锁期间,因胸痛就诊的急诊科人数和因ACS入院的人数分别减少了48.6%和51.1%。结论:COVID-19大流行和封锁本身对缺血性心脏病的负面影响超出了SARS-CoV-2感染。
{"title":"Impact of Coronavirus-19 Pandemic and Lockdown on Admissions for Ischemic Heart Disease.","authors":"Juan Enrique Puche García,&nbsp;Marta Iturregui Guevara,&nbsp;Etelvino Silva García,&nbsp;Raquel Campuzano Ruiz,&nbsp;Rafael Vázquez García","doi":"10.26502/fccm.92920270","DOIUrl":"https://doi.org/10.26502/fccm.92920270","url":null,"abstract":"<p><strong>Background: </strong>In early 2020, the SARS-CoV-2 pandemic caused an unprecedented overload for the health service. A decrease in admissions for Acute Coronary Syndrome (ACS) was reported during lockdown, although many aspects remain to be clarified. The main objective of this study was to evaluate the impact of the pandemic and of lockdown itself in this area.</p><p><strong>Methods: </strong>We performed a retrospective observational study based on data from patients who visited the emergency department of a tertiary hospital with chest pain during 2018-2020, as well as those who were admitted for ACS. Personal details, date of admission, additional test results (laboratory and echocardiography), and therapy were recorded. Patients were divided into 3 groups: preCOVID (n=1,301), lockdown (n=45), and postlockdown (n=343).</p><p><strong>Results: </strong>Fewer visits to the emergency department for chest pain and admissions for ACS were recorded during lockdown (48.6% and 51.1% respectively, p<0.05). Patients who were admitted during lockdown were characterized by poorer control of cardiovascular risk factors, visited later (more evolving infarctions: 2.7% vs. 14.3%, p<0.05), experienced more echocardiographic complications during admission, and had more than 3-fold mortality rates (both in-hospital and postdischarge).</p><p><strong>Conclusion: </strong>The COVID-19 pandemic and lockdown itself had a negative effect on ischemic heart disease beyond SARS-CoV-2 infection.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"6 4","pages":"353-363"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TLR-4 Inhibition Attenuates Inflammation, Thrombosis, and Stenosis in Arteriovenous Fistula in Yucatan Miniswine. TLR-4抑制减轻尤卡坦迷你葡萄酒动静脉瘘的炎症、血栓形成和狭窄。
Pub Date : 2022-01-01 Epub Date: 2022-08-26 DOI: 10.26502/fccm.92920280
Vikrant Rai, Mohamed M Radwan, Sunil Nooti, Finosh G Thankam, Harbinder Singh, Devendra K Agrawal

Arteriovenous fistula (AVF) is the preferred vascular access in hemodialysis patients; however, it is afflicted with a high failure rate. Chronic inflammation, excessive neointimal hyperplasia (NIH), vessel stenosis, early thrombosis, and failure of outward remodeling are the major causes of AVF maturation failure. Inflammatory mediator toll-like receptor (TLR)-4 plays a critical role in NIH, arterial thrombosis, and stenosis. We investigated the effect of TLR-4 inhibition on early thrombosis. Yucatan miniswine were used to create AVF involving femoral artery and femoral vein and treated with TLR-4 inhibitor TAK-242 with ethanol as the vehicle. The vessels were assessed after 12 weeks using histomorphometry, immunostaining, ultrasound, angiography, and optical coherence tomography. Inhibition of TLR-4 attenuated inflammation and early thrombosis in 50% of animals, and blood flow was present through AVF in 25% of animals. Thus, targeting TLR-4 to attenuate inflammation and early thrombosis might be a therapeutic approach to keep AVF patent and maintain blood flow through the outflow vein.

动静脉瘘(AVF)是血液透析患者首选的血管通路;然而,它的故障率很高。慢性炎症、过度新生内膜增生(NIH)、血管狭窄、早期血栓形成、外重构失败是AVF成熟衰竭的主要原因。炎症介质toll样受体(TLR)-4在NIH、动脉血栓形成和狭窄中起关键作用。我们研究了TLR-4抑制对早期血栓形成的影响。用尤卡坦小葡萄制造累及股动脉和股静脉的AVF,用TLR-4抑制剂TAK-242以乙醇为载体处理。12周后使用组织形态学、免疫染色、超声、血管造影和光学相干断层扫描对血管进行评估。抑制TLR-4可减轻50%动物的炎症和早期血栓形成,25%动物可通过AVF产生血流。因此,靶向TLR-4减轻炎症和早期血栓形成可能是保持AVF通畅和维持流出静脉血流的治疗途径。
{"title":"TLR-4 Inhibition Attenuates Inflammation, Thrombosis, and Stenosis in Arteriovenous Fistula in Yucatan Miniswine.","authors":"Vikrant Rai,&nbsp;Mohamed M Radwan,&nbsp;Sunil Nooti,&nbsp;Finosh G Thankam,&nbsp;Harbinder Singh,&nbsp;Devendra K Agrawal","doi":"10.26502/fccm.92920280","DOIUrl":"https://doi.org/10.26502/fccm.92920280","url":null,"abstract":"<p><p>Arteriovenous fistula (AVF) is the preferred vascular access in hemodialysis patients; however, it is afflicted with a high failure rate. Chronic inflammation, excessive neointimal hyperplasia (NIH), vessel stenosis, early thrombosis, and failure of outward remodeling are the major causes of AVF maturation failure. Inflammatory mediator toll-like receptor (TLR)-4 plays a critical role in NIH, arterial thrombosis, and stenosis. We investigated the effect of TLR-4 inhibition on early thrombosis. Yucatan miniswine were used to create AVF involving femoral artery and femoral vein and treated with TLR-4 inhibitor TAK-242 with ethanol as the vehicle. The vessels were assessed after 12 weeks using histomorphometry, immunostaining, ultrasound, angiography, and optical coherence tomography. Inhibition of TLR-4 attenuated inflammation and early thrombosis in 50% of animals, and blood flow was present through AVF in 25% of animals. Thus, targeting TLR-4 to attenuate inflammation and early thrombosis might be a therapeutic approach to keep AVF patent and maintain blood flow through the outflow vein.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"6 5","pages":"432-450"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33478340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Cardiology and cardiovascular medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1